[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"all-tumor-types\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:all-tumor-types":25},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":21,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":26,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":44},"100273106","specta-screening-cancer-patients-for-efficient-clinical-trial-access-100273106",false,"NCT02834884","SPECTA: Screening Cancer Patients for Efficient Clinical Trial Access","SPECTA","* Patients with pathologically confirmed selected tumor types (at site or centrally);\n* Mandatory availability of adequate human biological material (HBM);\n* Centrally performed confirmation of HBM adequacy in terms of quality and quantity for SPECTA downstream project requirements;\n* Age ≥ 12 years;\n* Absence of any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule;\n* Written informed consent according to applicable legal and ethical requirements;","ALL","12 Years",{"count":19,"type":20},4975,"ESTIMATED","5 Years","OBSERVATIONAL","SPECTA is a quality assured platform for collecting clinicopathologically annotated biological material, imaging data, operative images, environmental assessment, questionnaires as well as patient-reported outcomes from cancer patients to support biospecimen-based translational research and clinical cancer research, including biomarker discovery to improve the understanding of tumor biology and cancer patients care.",[25],"All Tumor Types",[27,28,29,30,31],"rare cancer","biomarker","molecular screening","cancer","biobanking","RECRUITING","2026-06-19",{"date":35,"type":36},"2026-06-24","ACTUAL",{"date":38,"type":36},"2017-05-03",{"date":40,"type":20},"2031-10",{"name":42,"class":43},"European Organisation for Research and Treatment of Cancer - EORTC","NETWORK",136]